Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 79

Sort by

Sort Order Select

Journal Articles

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukemia: A multi-center phase II expansion study

Katelyn Daniels, Stanley Pounds, Huiyun Wu, Lei Wang, Cyrus Mehr, Thomas Alexander, Amit Budhraja, Joshua Wolf, Tamara Westover, Paul Mead, Norman Lacayo, Ching-Hon Pui, Joseph Opferman, Jeffery Klco, Seth Karol

Blood (2025) 146 (Supplement 1): 649.

https://doi.org/10.1182/blood-2025-649

Published: 2025

Journal Articles

Retrospective analysis of 30mg/kg ATLG in preventing GVHD after haploidentical hematopoietic stem cell transplantation

Sanfang Tu, Minhong Huang, Chaoyang Song, Yuxian Huang, Rui Huang, Yanjie He, Shaojie Wu, Xuan Zhou, Jilong Yang, Chunyan Yue, Lei Wang, Yuhua Li

Blood (2025) 146 (Supplement 1): 7754.

https://doi.org/10.1182/blood-2025-7754

Published: 2025

Journal Articles

Impact of hereditary predisposition genes to hematologic malignancies on transplant outcomes and donor selection

Zhihui Li, Qinlong Zheng, Keyan Yang, Xianxuan Wang, Jing Li, Qian Fei, Jiahong Zhai, Zongyang Ming, lei wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2025) 146 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2025-1053

Published: 2025

Journal Articles

Impact of rilzabrutinib on gene-expression of inflammatory factors in patients with warm autoimmune hemolytic anemia who participated in the Phase 2B lumina 2 study

Alessandro Lucchesi, Nicola Cooper, Bruno Fattizzo, Lei Wang, Eric Boitier, Cintia C. Palu, Dimitri Carene, Vincent Mikol, Ahmed Daak, David Kuter

Blood (2025) 146 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2025-2881

Published: 2025

Journal Articles

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Blood (2025) 146 (Supplement 1): 88.

https://doi.org/10.1182/blood-2025-88

Published: 2025

Journal Articles

Deeper remission achievement and longer leukemia-free survival with inati-cel as consolidation therapy in allogeneic transplant-ineligible adolescent and adult patients with B-ALL

Sanfang Tu, Kaixin Ou, Lei Wang, Xuan Zhou, Chaoyang Song, Shaojie Wu, Rui Huang, Yanjie He, Yuxian Huang, Chunyan Yue, Minhong Huang, Yuhua Li

Blood (2025) 146 (Supplement 1): 3353.

https://doi.org/10.1182/blood-2025-3353

Published: 2025

Journal Articles

Fatigue, hemoglobin, and inflammatory markers in warm autoimmune hemolytic anemia: Analysis from a phase 2b trial of rilzabrutinib (LUMINA2)

David Kuter, Nicola Cooper, Mattea Orsini, Jerome Msihid, Laurence Pollissard, Matias Cordoba, Ahmed Daak, Marek Wardecki, Lei Wang, Bruno Fattizzo

Blood (2025) 146 (Supplement 1): 1105.

https://doi.org/10.1182/blood-2025-1105

Published: 2025

Journal Articles

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Blood (2025) 146 (Supplement 1): 603.

https://doi.org/10.1182/blood-2025-603

Published: 2025

Journal Articles

Clinical manifestations, risk factors and prognosis associated with central nervous system relapse after CAR-T therapy for R/R B-cell non-Hodgkin lymphoma: A multi-center analysis

Tianning Gu, Tingting Yang, Mengyu Zhao, Yetian Dong, Meng Zhu, Linghui Zhou, Mingming Zhang, Wenfa Huang, Lei Wang, Rongrong Chen, Delin Kong, Jiazhen Cui, Wenxiao Li, Lixin Wang, Yok Lam Kwong, He Huang, Yongxian Hu

Blood (2025) 146 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2025-6340

Published: 2025

Journal Articles

Outcome of bridging therapy in chimeric antigen receptor T cell treatment for Relapsed/Refractory B-cell non-Hodgkin lymphoma: A retrospective study.

Sanfang Tu, Langqi Wang, Shaojie Wu, Yanjie He, Chaoyang Song, Zhao Liang, Xuan Zhou, Lei Wang, Chunyan Yue, Lijuan Zhou, Jilong Yang, Yuhua Li

Blood (2025) 146 (Supplement 1): 8045.

https://doi.org/10.1182/blood-2025-8045

Published: 2025

Journal Articles

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Blood (2025) 146 (18): 2229–2243.

https://doi.org/10.1182/blood.2025028674

Published: 2025

Includes: Supplemental data

Journal Articles

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Allison Barz Leahy, Jennifer Brogdon, Lucy Cain, Amanda M. Dinofia, Joseph A. Fraietta, Richard Hanna, Stephan Kadauke, Raabia Khan, Yimei Li, Shannon L. Maude, Regina M. Myers, Laura Shinehouse, Anna Sparrow, Melissa Varghese, Lei Wang, Yongping Wang, Stephan A. Grupp

Blood (2024) 144 (Supplement 1): 3470.

https://doi.org/10.1182/blood-2024-204300

Published: 2024

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li, Xianxuan Wang, Keyan Yang, Lei Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 599.

https://doi.org/10.1182/blood-2024-200684

Published: 2024

Journal Articles

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Bian Renjie, Yi Qu, Danyang Wu, Jinxiang Yu, Xiaoxue Wang, Lei Wang, Juan He, Jun Wang, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 6466.

https://doi.org/10.1182/blood-2024-204890

Published: 2024

Journal Articles

Diagnosis and Prognosis of aGVHD By Metabolic Biomarkers after Allogeneic Hematopoietic Stem Cell Transplantation

Lei Wang, Ruigeng Yang, Shufeng Li, Jiancheng Fang, Xiaofei Luo, Wenli Sun, Chunfei Jiang, Meng Li, Yang Xue, Hongxing Liu

Blood (2024) 144 (Supplement 1): 2148.

https://doi.org/10.1182/blood-2024-200509

Published: 2024

Journal Articles

Quantifying the Effect of Posaconazole on Venetoclax Metabolism in Chinese Patients with Hematological Diseases

Lei Wang, Jian Cheng, Wenli Sun, Hai He, Meng Li, Yang Xue, Jing Xing, Tengkuan Wang, Hongxing Liu

Blood (2024) 144 (Supplement 1): 5776.

https://doi.org/10.1182/blood-2024-200557

Published: 2024

Journal Articles

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Rohith Jesudas, Lei Wang, Yan Chen, Sedigheh Mirzaei, Siddhant Taneja, Kirsten K Ness, Matthew J. Ehrhardt, Stephanie B Dixon, Bonnie Ky, Melissa M. Hudson, Clifford M. Takemoto, Daniel M. Green, Daniel A. Mulrooney

Blood (2024) 144 (Supplement 1): 698.

https://doi.org/10.1182/blood-2024-203521

Published: 2024

Journal Articles

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Zhihui Li, Keyan Yang, Lei Wang, Xianxuan Wang, Xiaopei Wen, Jingjing Wang, Jing Li, Yanzhi Song, Yongqiang Zhao, Qinlong Zheng, Tong Wu

Blood (2024) 144 (Supplement 1): 4922.

https://doi.org/10.1182/blood-2024-200716

Published: 2024

Journal Articles

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Chuting Yang, Yaling Zheng, Chaoyang Song, Ming Wu, Lei Wang, Xuan Zhou, Chunyan Yue, Xiaonan Lin, Jie Chen, Hui Zeng, Rui Huang, Yuhua Li

Blood (2023) 142 (Supplement 1): 7045.

https://doi.org/10.1182/blood-2023-174879

Published: 2023

Journal Articles

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Zhihui Li, Qinlong Zheng, Keyan Yang, Teng Xu, Lei Wang, Xianxuan Wang, Xiaopei Wen, Yanzhi Song, Yongqiang Zhao, Tong Wu

Blood (2023) 142 (Supplement 1): 239.

https://doi.org/10.1182/blood-2023-180834

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukemia: A multi-center phase II expansion study

Retrospective analysis of 30mg/kg ATLG in preventing GVHD after haploidentical hematopoietic stem cell transplantation

Impact of hereditary predisposition genes to hematologic malignancies on transplant outcomes and donor selection

Impact of rilzabrutinib on gene-expression of inflammatory factors in patients with warm autoimmune hemolytic anemia who participated in the Phase 2B lumina 2 study

Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)

Deeper remission achievement and longer leukemia-free survival with inati-cel as consolidation therapy in allogeneic transplant-ineligible adolescent and adult patients with B-ALL

Fatigue, hemoglobin, and inflammatory markers in warm autoimmune hemolytic anemia: Analysis from a phase 2b trial of rilzabrutinib (LUMINA2)

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Clinical manifestations, risk factors and prognosis associated with central nervous system relapse after CAR-T therapy for R/R B-cell non-Hodgkin lymphoma: A multi-center analysis

Outcome of bridging therapy in chimeric antigen receptor T cell treatment for Relapsed/Refractory B-cell non-Hodgkin lymphoma: A retrospective study.

Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia

Cost-Effective Manufacture and Promising Initial Efficacy of huCART19 Cells Manufactured Using the Clinimacs Prodigy Platform

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Diagnosis and Prognosis of aGVHD By Metabolic Biomarkers after Allogeneic Hematopoietic Stem Cell Transplantation

Quantifying the Effect of Posaconazole on Venetoclax Metabolism in Chinese Patients with Hematological Diseases

Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study

Influence of Somatic and Germline Gene Variants on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only